{
    "2020-04-01": [
        [
            {
                "time": "",
                "original_text": "[年报]健帆生物2019年净利润同比增长42% 拟10转9派9元",
                "features": {
                    "keywords": [
                        "健帆生物",
                        "2019年",
                        "净利润",
                        "同比增长",
                        "42%",
                        "10转9派9元"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "健帆生物：2019年净利同比增42% 拟10转9派9元",
                "features": {
                    "keywords": [
                        "健帆生物",
                        "2019年",
                        "净利",
                        "同比增",
                        "42%",
                        "10转9派9元"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "健帆生物(300529.SZ)拟斥1亿元设立全资子公司珠海健航",
                "features": {
                    "keywords": [
                        "健帆生物",
                        "300529.SZ",
                        "1亿元",
                        "全资子公司",
                        "珠海健航"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "健帆生物：2019年净利同比42%，拟10转9派9元",
                "features": {
                    "keywords": [
                        "健帆生物",
                        "2019年",
                        "净利",
                        "同比",
                        "42%",
                        "10转9派9元"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【广证恒生医药】健帆生物（300529.SZ）-年度点评-灌流器持续渗透放量，2019年扣非业绩实现48%超高速增长",
                "features": {
                    "keywords": [
                        "广证恒生医药",
                        "健帆生物",
                        "300529.SZ",
                        "年度点评",
                        "灌流器",
                        "持续渗透",
                        "放量",
                        "2019年",
                        "扣非业绩",
                        "48%",
                        "超高速增长"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}